Fundació Institut D'Investigació Biomèdica de Bellvitge (IDIBELL);Fundació Institució Catalana de Recerca I Estudis Avançats (ICREA);Administración General de la Comunidad Autónoma de Euskadi;Universi
发明人:
申请号：
EP16739131.7
公开号：
EP3322980B1
申请日:
2016.07.14
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention is directed to a diagnostic method for adrenoleukodystrophy in a subject based on the determination of the levels of different markers. The invention also provides a method for monitoring the progression of an adrenoleukodystrophy, a method for monitoring the effect of an adrenoleukodystrophy therapy and fingolimod, an analogue, metabolite or derivative thereof, or a pharmaceutically acceptable salt thereof, for use in the treatment and/or prevention of an adrenoleukodystrophy.
